Evaluation of the Pharmaceutical Industry Investment Program
With the expiry of the Pharmaceutical Industry Investment Program (PIIP) in 2004, the Commission was asked to conduct an evaluation of the program’s rationale, effectiveness and efficiency. The study commenced in August 2002. The Commission found that this assistance scheme had significant deficiencies and should not be renewed in its current form when it expires.
When requesting a correction, please mention this item's handle: RePEc:wpa:wuwpmi:0305001. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (EconWPA)
If references are entirely missing, you can add them using this form.